OBJECTIVE: To assess the impact of the non-pneumatic anti-shock garment (NASG) on maternal outcome following severe obstetric hemorrhage. METHODS: A non-randomized pre-intervention/intervention study was conducted in 2 tertiary hospitals in Egypt from June 2006 to May 2008. Women with obstetric hemorrhage (estimated blood loss >or=1000 mL and/or >or=1 sign of shock [systolic blood pressure <100 mm Hg or pulse >100 beats per minute]) were treated with either a standardized protocol (pre-intervention) or a standardized protocol plus the NASG (intervention). The primary outcome was extreme adverse outcome (EAO), combining maternal mortality and severe morbidity (cardiac, respiratory, renal, or cerebral dysfunction). Secondary outcomes were measured blood loss, urine output, emergency hysterectomy, and (individually) mortality or morbidity. Analyses were performed to examine independent association of the NASG with EAO. RESULTS: Mean measured blood loss decreased from 379 mL pre-intervention to 253 mL in the intervention group (P<0.01). In a multiple logistic regression model, the NASG was associated with reduced odds of EAO (odds ratio 0.38; 95% confidence interval, 0.17-0.85). CONCLUSION: The NASG, in addition to standardized protocols at tertiary facilities for obstetric hemorrhage and shock, resulted in lower measured blood loss and reduced EAO. Copyright 2010 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.
OBJECTIVE: To assess the impact of the non-pneumatic anti-shock garment (NASG) on maternal outcome following severe obstetric hemorrhage. METHODS: A non-randomized pre-intervention/intervention study was conducted in 2 tertiary hospitals in Egypt from June 2006 to May 2008. Women with obstetric hemorrhage (estimated blood loss >or=1000 mL and/or >or=1 sign of shock [systolic blood pressure <100 mm Hg or pulse >100 beats per minute]) were treated with either a standardized protocol (pre-intervention) or a standardized protocol plus the NASG (intervention). The primary outcome was extreme adverse outcome (EAO), combining maternal mortality and severe morbidity (cardiac, respiratory, renal, or cerebral dysfunction). Secondary outcomes were measured blood loss, urine output, emergency hysterectomy, and (individually) mortality or morbidity. Analyses were performed to examine independent association of the NASG with EAO. RESULTS: Mean measured blood loss decreased from 379 mL pre-intervention to 253 mL in the intervention group (P<0.01). In a multiple logistic regression model, the NASG was associated with reduced odds of EAO (odds ratio 0.38; 95% confidence interval, 0.17-0.85). CONCLUSION: The NASG, in addition to standardized protocols at tertiary facilities for obstetric hemorrhage and shock, resulted in lower measured blood loss and reduced EAO. Copyright 2010 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.
Authors: Janet Turan; Oladosu Ojengbede; Mohamed Fathalla; Mohammed Mourad-Youssif; Imran O Morhason-Bello; David Nsima; Jessica Morris; Elizabeth Butrick; Hilarie Martin; Carol Camlin; Suellen Miller Journal: J Womens Health (Larchmt) Date: 2010-12-29 Impact factor: 2.681
Authors: Suellen Miller; Mohamed M F Fathalla; Oladosu A Ojengbede; Carol Camlin; Mohammed Mourad-Youssif; Imran O Morhason-Bello; Hadiza Galadanci; David Nsima; Elizabeth Butrick; Tarek Al Hussaini; Janet Turan; Carinne Meyer; Hilarie Martin; Aminu I Mohammed Journal: BMC Pregnancy Childbirth Date: 2010-10-18 Impact factor: 3.007
Authors: Mohammed Mourad-Youssif; Oladosu A Ojengbede; Carinne D Meyer; Mohammad Fathalla; Imran O Morhason-Bello; Hadiza Galadanci; Carol Camlin; David Nsima; Tarek Al Hussaini; Elizabeth Butrick; Suellen Miller Journal: Reprod Health Date: 2010-09-01 Impact factor: 3.223
Authors: Mohamed M F Fathalla; Mohammed Mourad Youssif; Carinne Meyer; Carol Camlin; Janet Turan; Jessica Morris; Elizabeth Butrick; Suellen Miller Journal: ISRN Obstet Gynecol Date: 2011-08-10
Authors: Cynthia Pileggi-Castro; Vicky Nogueira-Pileggi; Özge Tunçalp; Olufemi Taiwo Oladapo; Joshua Peter Vogel; João Paulo Souza Journal: Reprod Health Date: 2015-03-31 Impact factor: 3.223
Authors: María Fernanda Escobar; Carlos Eduardo Füchtner; Javier Andrés Carvajal; Albaro José Nieto; Adriana Messa; Sara Sofía Escobar; Angélica María Monroy; Angélica María Forero; José David Casallas; Marcela Granados; Suellen Miller Journal: Reprod Health Date: 2017-05-12 Impact factor: 3.223
Authors: Tori Sutherland; Janelle Downing; Suellen Miller; David M Bishai; Elizabeth Butrick; Mohamed M F Fathalla; Mohammed Mourad-Youssif; Oladosu Ojengbede; David Nsima; James G Kahn Journal: PLoS One Date: 2013-04-30 Impact factor: 3.240
Authors: Suellen Miller; Eduardo F Bergel; Alison M El Ayadi; Luz Gibbons; Elizabeth A Butrick; Thulani Magwali; Gricelia Mkumba; Christine Kaseba; N T My Huong; Jillian D Geissler; Mario Merialdi Journal: PLoS One Date: 2013-10-23 Impact factor: 3.240
Authors: Alison M El Ayadi; Elizabeth Butrick; Jillian Geissler; Suellen Miller Journal: BMC Pregnancy Childbirth Date: 2013-11-15 Impact factor: 3.007